<DOC>
	<DOCNO>NCT00511342</DOCNO>
	<brief_summary>The primary purpose study evaluate effect NOMAC-E2 combine oral contraceptive ( COC ) bone mineral density ( BMD ) .</brief_summary>
	<brief_title>Effects Bone Mineral Density ( BMD ) Combined Oral Contraceptive NOMAC-E2 Compared COC Containing LNG/EE ( 292005 ) ( P05765 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Inclusion criterion : Sexually active woman , risk pregnancy planning use condom treatment ; At least 20 old 35 year age time screen ; BMI = 17 = 35 ; Good physical mental health ; Willing give informed consent writing ; Willing take part trial two year . Exclusion criterion : Family history osteoporotic fracture age 70 ; Postgastrectomy ; History eat disorder , viz . anorexia nervosa , bulimia ; Endocrine disorder ( include control diabetes , [ para ] thyroid disease , Cushing 's disease ) ; Rheumatoid arthritis ; Significant scoliosis ; Fasting parathyroid hormone ( PTH ) outside reference range screening ; Fasting calcitonin outside reference range screening ; Prolactin reference range ( hyperprolactinemia ) screening ; Fasting cholesterol and/or triglyceride reference range age screening ( treatment lipid lower drug allow ) ; Engaging vigorous exercise marathon , competitive swimming , triathlon ; Smoking ten cigarettes/day ; Use two unit alcohol day ; Use one follow drug : gonadotropin release hormone ( GnRH ) analogue ( also past use six month time , period time le six month ago contraindication ) ; systemic inhaled administration corticosteroid ( also past use one year , less five year ago period time past year contraindication ) ; thiazide diuretic ; thyroid hormone ; bisphosphonates ; calcium supplementation combination vitamin D supplementation/ calcitonin ; ever treatment childhood fluoride ; Contraindications contraceptive steroid An abnormal cervical smear ( i.e . : dysplasia , cervical intraepithelial neoplasia [ CIN ] , squamous intraepithelial lesion [ SIL ] , carcinoma situ , invasive carcinoma ) screening ; Clinically relevant abnormal laboratory result screen judged investigator ; Use injectable hormonal method contraception ; within 6 month injection 3month duration , within 4 month injection 2month duration , within 2 month injection 1month duration ; Within 12 month pregnancy prior start trial medication ; Breastfeeding within 12 month stop breastfeed prior start trial medication ; Present use use within 2 month prior start trial medication follow drug : phenytoin , barbiturate , primidone , carbamazepine , oxcarbazepine , topiramate , felbamate , rifampicin , nelfinavir , ritonavir , griseofulvin , ketoconazole , sex steroid ( pre posttreatment contraceptive method ) herbal remedy contain Hypericum perforatum ( St John 's Wort ) ; Administration investigational drug and/or participation another clinical trial within 2 month prior start trial medication trial period .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>